Brain radiotherapy for breast cancer with brain metastases
Part of Brain & nervous system, Cancer, Skin clinical trials.
This trial tests a new type of whole-brain radiotherapy that avoids the hippocampus (a brain area important for memory) in people whose breast cancer has spread to the brain. It is for those who cannot have the focused kind of radiation (stereotactic radiotherapy) and might help preserve memory while treating the tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that has spread to your brain (seen on an MRI).
- Your doctor thinks whole-brain radiotherapy is the best option for you (instead of focused radiation).
- You are 16 years or older and live in the United Kingdom.
- You are well enough to do daily activities (ECOG score 0, 1, or 2).
- You can answer questions about your quality of life and symptoms over the phone.
- You are expected to live more than 3 months from other cancer in your body (outside the brain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of radiation therapy (iHD-SRT) for people with brain metastases. It aims to see if this approach is safe and effective for treating tumors that have spread to the brain.
This Phase 2 study tests a quicker, more targeted way to give radiation to brain metastases. It aims to treat tumors while using regular scans to check how well the treatment controls disease and how you feel.
This trial tests a local treatment approach (focused radiation) for people with multiple brain metastases. It may help by targeting several spots in the brain while keeping treatment within certain size and safety limits.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This Phase 2 study tests a treatment plan that combines whole-brain radiation therapy with an additional approach to help people with brain metastases. It aims to improve outcomes while also tracking brain function and memory over time.
This trial compares two ways of giving radiation to the brain for people with 5 or more brain metastases: focused stereotactic radiosurgery, or a whole-brain approach that tries to spare the memory area (with memantine). It aims to see which method better protects thinking and memory while still treating the tumors.
Hear when a new Brain Metastases, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.